The LAVA™ family of devices separates and concentrates biologic fluids to create supraphysiologic cell solutions such as Platelet Rich Plasma and Bone Marrow Concentrates.​

LAVA™ cell concentration technology provides the shortest processing times with the smallest and lightest design, consistently delivering high-quality output. High cell concentration and yield with low variability offers more predictable device output​. Lightest weight and most portable device that can be carried where it is needed most, whether in the office, bedside, or in the field.​

7X

Greater than 7X platelet concentration

60

60 second spine time​

3.2%

3.2% variance – predictable device output​

Lightest weight and most portable device​:

  • 5 x 5 footprint​
  • Less than 4 lbs, fully loaded​

Fast and easy​:

  • 5 times faster than market leading devices​
  • Simple 3-step process

 

Markets served by this technology

  • Orthopedics

    DSM Biomedical materials and technologies support orthopedic applications, including spine, trauma and sports medicine. Learn more.

  • Wound Management

    DSM Biomedical materials and technologies support wound management and wound applications. Learn more.

LAVA™ Cell concentration technology

Read more

  • Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

Want to get in touch?

We'd love to hear from you!

This site uses cookies to store information on your computer.

Learn more